首页> 美国卫生研究院文献>Springer Open Choice >A pathway from chromosome transfer to engineering resulting in human and mouse artificial chromosomes for a variety of applications to bio-medical challenges
【2h】

A pathway from chromosome transfer to engineering resulting in human and mouse artificial chromosomes for a variety of applications to bio-medical challenges

机译:从染色体转移到工程的途径导致人类和小鼠的人工染色体在生物医学挑战中的多种应用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Microcell-mediated chromosome transfer (MMCT) is a technique to transfer a chromosome from defined donor cells into recipient cells and to manipulate chromosomes as gene delivery vectors and open a new avenue in somatic cell genetics. However, it is difficult to uncover the function of a single specific gene via the transfer of an entire chromosome or fragment, because each chromosome or fragment contains a set of numerous genes. Thus, alternative tools are human artificial chromosome (HAC) and mouse artificial chromosome (MAC) vectors, which can carry a gene or genes of interest. HACs/MACs have been generated mainly by either a “top-down approach” (engineered creation) or a “bottom-up approach” (de novo creation). HACs/MACs with one or more acceptor sites exhibit several characteristics required by an ideal gene delivery vector, including stable episomal maintenance and the capacity to carry large genomic loci plus their regulatory elements, thus allowing the physiological regulation of the introduced gene in a manner similar to that of native chromosomes. The MMCT technique is also applied for manipulating HACs and MACs in donor cells and delivering them to recipient cells. This review describes the lessons learned and prospects identified from studies on the construction of HACs and MACs, and their ability to drive exogenous gene expression in cultured cells and transgenic animals via MMCT. New avenues for a variety of applications to bio-medical challenges are also proposed.
机译:微细胞介导的染色体转移(MMCT)是一种将染色体从定义的供体细胞转移到受体细胞中并操纵染色体作为基因传递载体的技术,并为体细胞遗传学开辟了一条新途径。但是,由于每个染色体或片段都包含一组众多基因,因此很难通过转移整个染色体或片段来揭示单个特定基因的功能。因此,替代工具是人类人工染色体(HAC)和小鼠人工染色体(MAC)载体,它们可以携带一个或多个目标基因。 HAC / MAC主要是通过“自上而下的方法”(工程创建)或“自下而上的方法”(从头创建)生成的。具有一个或多个受体位点的HAC / MAC表现出理想的基因传递载体所需的几个特征,包括稳定的游离维持和携带大基因组位点及其调节元件的能力,从而允许以类似方式对引入的基因进行生理调节到天然染色体。 MMCT技术还应用于操纵供体细胞中的HAC和MAC,并将其递送至受体细胞。这篇综述描述了从HAC和MACs的构建研究中汲取的教训和鉴定的前景,以及它们通过MMCT驱动培养的细胞和转基因动物中外源基因表达的能力。还提出了针对生物医学挑战的各种应用的新途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号